Lv6
2220 积分 2022-02-10 加入
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): a systematic review
3天前
已完结
2017 HRS/EHRA/ECAS/APHRS/ SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
3天前
已完结
Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia
14天前
已完结
Efficacy of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, delivered in a single spray, for the treatment of seasonal allergic rhinitis: results from Russia
14天前
已完结
Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: the ARIA-MASK-air® approach
14天前
已完结
MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis. J Asthma Allergy
14天前
已完结
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis
14天前
已完结
A randomized, double-blind, placebo-controlled study of the efficacy and safety of MP-AzeFlu for the treatment of seasonal allergic rhinitis
14天前
已完结
Next-generation ARIA guidelines for allergic rhinitis
14天前
已完结
皖公网安备34019202002308
